| abstract |
FIELD OF THE INVENTION The present invention generally relates to the field of therapy, and more particularly to the field of therapy for herpes simplex and herpes zoster, more particularly polyethylene glycol (PEG) or Reduction in the recurrence rate of herpes labialis (cold sore on the lips), genital herpes (genital herpes), and shingles (shingles, zona) by topical administration of a composition comprising PEG, Retardation of relapse, and / or prevention of relapse. |